FINANCIALS

Our latest financial reports, SEC filings, annual reports, consolidated key figures and financial calendar provide our shareholders and the financial community with relevant financial information.

SEC Filings

SEC Filings

Document Date	Description	Filing Group	View
Apr 13, 2018	Post-effective amendment to a previously filed F-6	Registration Statements	0001193805-18-000534.pdf 0001193805-18-000534.rtf 0001193805-18-000534.xls View HTML
Feb 05, 2019	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Registration Statements	0000912057-19-000036.pdf 0000912057-19-000036.rtf 0000912057-19-000036.xls View HTML
Apr 02, 2019	mendment to a previously filed DRS	Registration Statements	0000912057-19-000140.pdf 0000912057-19-000140.rtf 0000912057-19-000140.xls View HTML
May 13, 2019	mendment to a previously filed DRS	Registration Statements	0000912057-19-000214.pdf 0000912057-19-000214.rtf 0000912057-19-000214.xls View HTML
May 28, 2019	Registration statement for certain foreign private issuers	Registration Statements	0001047469-19-003334.pdf 0001047469-19-003334.rtf 0001047469-19-003334.xls View HTML
Jun 30, 2019	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-19-008146.pdf 0001558370-19-008146.rtf 0001558370-19-008146.xls EX-101.INS View HTML
Jul 09, 2019	This filing is a pre-effective amendment to an F-1 filing	Registration Statements	0001047469-19-004052.pdf 0001047469-19-004052.rtf 0001047469-19-004052.xls View HTML
Jul 12, 2019	FWP	Other	0001104659-19-040007.pdf 0001104659-19-040007.rtf View HTML
Jul 12, 2019	FWP	Other	0001104659-19-040088.pdf 0001104659-19-040088.rtf View HTML
Jul 12, 2019	Registration of certain classes of securities 12(b) of the Securities Exchange Act	Registration Statements	0001104659-19-040204.pdf 0001104659-19-040204.rtf 0001104659-19-040204.xls View HTML

Data provided by Kaleidoscope.

Who we are

Read about Genmab's purpose, core values and key accomplishments

Learn more
Turning insights into medicine

See the results of innovation that is rooted in science

Explore the pipeline
Innovation for the future

We are developing next-generation technologies

See our technologies

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.